Featured Articles
-
Lentiviral Vectors: The Key To Cell And Gene Therapy Success
7/30/2025
Lentiviral vector manufacturing is complex and highly regulated, which is why a specialized CDMO is required to ensure safe, scalable, and compliant production from early development to commercialization.
-
Shedding Light On Photo-Stability Forced Degradation
11/26/2024
Ensure the stability and safety of your drug products by utilizing comprehensive forced degradation and photo-stability testing, guided by ICH and FDA standards, to identify degradation pathways and assess light exposure risks.
-
Evolution Of An Adherent HEK293 Cell Line Into A cGMP Serum-free Suspension Cell Line
9/16/2024
Learn how cutting-edge advancements in viral vector production and innovative cell line development are overcoming the challenges of scaling gene and cell therapies.
-
2025 And Beyond — A Look At Upcoming NDSRI Regulations
9/12/2024
Learn from experts and secure reliable testing solutions to eliminate the presence of nitrosamine drug substance-related impurities (NDSRIs) in medications.